SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-286509
Filing Date
2011-10-28
Accepted
2011-10-28 17:22:33
Documents
7
Period of Report
2011-10-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d249039d8k.htm 8-K 18837
2 EX-1.1 d249039dex11.htm EX-1.1 102664
3 EX-4.1 d249039dex41.htm EX-4.1 78092
4 EX-5.1 d249039dex51.htm EX-5.1 12183
5 EX-99.1 d249039dex991.htm EX-99.1 8696
6 GRAPHIC g249039ex99_1pg001.jpg GRAPHIC 8400
7 GRAPHIC g249039g39c59.jpg GRAPHIC 1761
  Complete submission text file 0001193125-11-286509.txt   236052
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1370 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1370 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICAL PARTNERS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 111166107
SIC: 2834 Pharmaceutical Preparations